No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.

We assessed the effectiveness of cetuximab plus chronomodulated irinotecan, 5-fluorouracil (5-FU), leucovorin ... in 93% and 36% of patients before and after dose reduction.

We have now investigated its efficacy and toxicity in patients who have progressed during or after docetaxel chemotherapy. Results: Patients had a median age of 70 years (range 48-77), median baseline ...

Fluoropyrimidine chemotherapy with agents such as 5-fluorouracil ... of 5-FU in tumour after bolus injection. Therefore, carbogen breathing was initiated 1 min before 5-FU injection and ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

Each patient had two patches microneedled with a dermapen before having one patch treated with an application of 5-fluorouracil and the other patch treated with tacrolimus. Patients had treatment ...

ORLANDO — Topical 5-fluorouracil and calcipotriene proved ... a characteristic that Ruiz states did not impact the endpoints. After a follow-up time of 15 months, results showed that 92% of ...

Topical fluorouracil is available as Carac, Efudex, Tolak, and generic topical fluorouracil in the following dosage forms that are applied to the skin. 0.5% topical cream 4% topical cream 5% ...

The rates of death from toxic effects were 2.3% in the TPF group and 5.5% in the PF group. As compared with the standard regimen of cisplatin and fluorouracil ... before radiotherapy and 3 months ...

Patients were assessed before randomization ... Group Given Fluorouracil, Leucovorin, and Oxaliplatin. Twelve patients — six in each group (0.5 percent) — died within 1 month after the ...